A new paper from our postdoctorate fellow Dr. Ashley Dowd discusses the results of a cross-sectional survey (n=370) inquiring about patterns of use for those who consume oral cannabis products. sciencedirect.com/science/articl… We found that:

Colleagues, please see and share this paper on #fentanyl absorption, distribution, metabolism, and excretion. The take-home is that fentanyl is so lipophilic it is sequestered peripherally into muscle and fat 1/3 journals.lww.com/journaladdicti…

I have tested the effects of a lot of medications for their potential to treat Cannabis Use Disorder and AEF0117 shows the most promise by far. This has been an exciting journey!

As a follow up to our paper showing important PK/PD interactions between high dose CBD and THC - it’s all about the CYPs

In case you missed it - High dose CBD can affect other commonly used medications people take. See our Open access paper on Cytochrome P450‐Mediated Cannabinoid‐Drug Interactions in Healthy Adult Participants - Wiley Online Library ascpt.onlinelibrary.wiley.com/doi/10.1002/cp…

Please attend our 9/15/2023 CureAddictionNow forum on #SUDs featuring my impressive colleagues Cecilia Bergeria and @CassieGipson3 among others. We'll discuss #xylazine, #craving, #fentanyl, #overdose and more. Registration is free! cureaddictionnow.org/forum/

New review with some of my favorite people Margaret Haney is moving to bluesky @MegHaney Cece Hillard the tiniest doomwook Haley V on current state of endocannabinoid based therapeutics in the context of psychiatric illlness, with a focus on substance use disorders, trauma-related disorders and ASD. cambridge.org/core/product/i…

Early career faculty members- apply now to be an editorial fellow for Kelly@ECP for the 2024 year! Learn more about the editorial process and earn an honorarium. Applications are open here or below until Dec 1! tinyurl.com/ECPeditorialfe…

Klaus Miczek was a giant of Psychopharmacology: the field and the journal. R.I.P. Here's an interview from 2022. He covers his transformative impact on the journal, evolution of the field, @Psychopharm v Neuropsychopharmacology, writing/editing success, & more. youtu.be/PlUUZ8olWEY?si…

This shook me today. Klaus was my graduate school mentor for my Masters degree and my PhD. He had the biggest impact on my scientific development than anyone else. Thank you, Klaus, and may you rest in greatness.

One of my favorite aspects of science is getting to play in the sandbox with friends & colleagues and seeing the integration of different research streams come together. I am very privileged to have gotten to go on this scientific journey with Sheena Josselyn Sylvie Lesuis and Paul Frankland

Just in case - started on #Bluesky You can find me @ EliseWeerts.Bsky.social Let’s see how it goes.

Amazing work by DBB's Bryan W Jenkins 🧠 on summarizing the effects of prenatal cannabinoids on the brain and behavior! Online today - in NBBR Elise Weerts sciencedirect.com/science/articl…

sciencedirect.com/science/articl… New paper from our lab with Bryan W Jenkins 🧠 and Cassie Moore CBD interactions with THC may not be what you expect

Check out this new review from Maggie Bedillion, PhD and our amazing collaborators at Johns Hopkins. Where are we in developing medications to treat CUD and what do we need to do to move the needle? Hint: Maybe listen a bit to patients, many of whom are not interested in abstinence.